Sanofi-Genzyme BioVentures

Sanofi-Genzyme BioVentures

Sanofi-Genzyme BioVentures

Suggest edits
Follow us
Also headquartered in Cambridge
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 14

Portfolio

Portfolio Tracker

Add info
Add round
27 May 2020
Q32Bio
Q32Bio
$46,000,000
Venture capital (Series A)
Atlas Venture, Abingworth, OrbiMed, +3

Q32 Bio Raises $46M in Series A Funding

FinSMEs
09 Apr 2020
i2o Therapeutics
i2o Therapeutics
$4,000,000
Seed fund
Sanofi-Genzyme BioVentures, JDRF T1D Fund

i2O Therapeutics Raises $4m in Seed Funding

FinSMEs
+1
14 Dec 2017
Curisium
Curisium
$3,500,000
Seed fund
Flare Capital Partners, Sanofi-Genzyme BioVentures, Green Bay Ventures, +2
20 Jul 2017
Neurovia
Neurovia
$14,000,000
Venture capital (Series A)
Novartis Venture Fund, BioMed Ventures, Enso Ventures, +1

NeuroVia scores $14 mln Series A

PE HUB
20 Jul 2017
NeuroVia
NeuroVia
$14,000,000
Venture capital (Series A)
Novartis Venture Fund, BioMed Ventures, Enso Ventures, +1

Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work

FierceBiotech
+2
14 Jun 2017
Omada Health
Omada Health
$50,000,000
Venture capital (Series D)
Sanofi-Genzyme BioVentures, Cigna, Civilization Ventures

Omada Health reels in $50 mln

PE HUB
27 Apr 2017
Evidation Health
Evidation Health
$10,000,000
Venture capital
GE Ventures, Sanofi-Genzyme BioVentures, B Capital Group

Evidation Health takes in $10 mln

PE HUB
18 Oct 2016
Science 37
Science 37
$31,000,000
Venture capital (Series B)
Redmile Group, Lux Capital, Sanofi-Genzyme BioVentures, +1

Science 37 raises $31 million to bring clinical trials to the home

VentureBeat
30 Mar 2016
immuneXcite
immuneXcite
$8,600,000
Venture capital (Series A)
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures

ImmuneXcite Completes $8.6M Series A-1 Financing

FinSMEs
+1
30 Mar 2016
immuneXcite
immuneXcite
$8,600,000
Venture capital (Series A)
Partners Innovation Fund, Cormorant Asset Management, Sanofi-Genzyme BioVentures

Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round

FierceBiotech
+1
18 Dec 2015
Navitor Pharma
Navitor Pharma
$33,000,000
Venture capital (Series B)
Atlas Venture, Polaris Partners, SR One, +4

Navitor Pharmaceuticals Announces $33 Million Series B Financing

businesswire
11 Aug 2015
Ovid Therapeutics
Ovid Therapeutics
$75,000,000
Venture capital (Series B)
Redmile Group, Fidelity Management and Research Company, Jennison Associates, +5

Ex-Teva CEO's Brain Disease Startup, Ovid, Bags $75M From Crossovers

Xconomy
11 Jun 2015
Unum Therapeutics
Unum Therapeutics
$65,000,000
Venture capital (Series B)
Atlas Venture, Wellington Management, New Leaf Venture Partners, +9
21 Oct 2014
Unum Therapeutics
Unum Therapeutics
$12,000,000
Venture capital (Series A)
Atlas Venture, Fidelity Biosciences, Sanofi-Genzyme BioVentures